Money Concepts Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,110
Closed -$282K 368
2023
Q1
$282K Buy
23,110
+19,501
+540% +$604K 0.02% 361
2022
Q4
$102K Buy
3,609
+1,947
+117% +$61.8K ﹤0.01% 952
2022
Q3
$55K Sell
1,662
-3
-0.2% -$110 ﹤0.01% 695
2022
Q2
$55K Sell
1,665
-4,623
-74% -$162K ﹤0.01% 681
2022
Q1
$289K Buy
6,288
+4,143
+193% +$198K 0.02% 592
2021
Q4
$131K Buy
+2,145
New +$148K 0.01% 527
2021
Q1
$907K Sell
10,219
-1,358
-12% -$135K 0.07% 223
2020
Q4
$1.08M Buy
+11,577
New +$922K 0.1% 175

Other funds holding ARKG

Money Concepts Capital's ARKG Position: Q2 2023 in Review

Money Concepts Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 23,110 shares — an estimated $282K sold.

Money Concepts Capital first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $1.08M in Q4 2020. 290 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

  • Money Concepts Capital reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
  • Money Concepts Capital sold 23,110 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $282K.
  • Money Concepts Capital first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
  • Money Concepts Capital's ARK Genomic Revolution ETF position peaked at $1.08M in Q4 2020.
  • 290 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Money Concepts Capital's 13F filing for Q2 2023, filed 1 Aug 2023.